Skip to main content
. Author manuscript; available in PMC: 2020 Jan 13.
Published in final edited form as: Exp Mol Pathol. 2016 Oct 3;101(2):281–289. doi: 10.1016/j.yexmp.2016.10.001

Fig. 4.

Fig. 4.

Binding of D6 and E11 to human NK cells. Positive and negative controls refer to the binding of PE-conjugated mouse-anti-CD16A IgG1 and the PE-conjugated anti-FLAG antibody alone (in the absence of D6 or E11) binding to cells, respectively. Each measurement was repeated three times and the positive binding cells percentage and fluorescence data were listed as means ± standard deviations. (A) D6 and E11 binding to human NK cells expressing CD16A at low concentration of 10 nM. (B) D6 and E11 at the same concentrations binding to Jurkat T cells which do not express CD16A. (C) D6 and E11 binding to phorbol myristate acetate (PMA) activated U937 cells which express FcγRI and FcγRII but not FcγRIII.